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Polyol synthesis, functionalisation, and
biocompatibility studies of superparamagnetic
iron oxide nanoparticles as potential MRI
contrast agents†
Roxanne Hachani,a,b Mark Lowdell,c Martin Birchall,d Aziliz Hervault,a,b
Damien Mertz,e Sylvie Begin-Coline and Nguyê˜n Thi ̣Kim Thanh*a,b
Iron oxide nanoparticles (IONPs) of low polydispersity were obtained through a simple polyol synthesis in
high pressure and high temperature conditions. The control of the size and morphology of the nano-
particles was studied by varying the solvent used, the amount of iron precursor and the reaction time.
Compared with conventional synthesis methods such as thermal decomposition or co-precipitation, this
process yields nanoparticles with a narrow particle size distribution in a simple, reproducible and cost
eﬀective manner without the need for an inert atmosphere. For example, IONPs with a diameter of
ca. 8 nm could be made in a reproducible manner and with good crystallinity as evidenced by X-ray diﬀrac-
tion analysis and high saturation magnetization value (84.5 emu g−1). The surface of the IONPs could be
tailored post synthesis with two diﬀerent ligands which provided functionality and stability in water and
phosphate buﬀer saline (PBS). Their potential as a magnetic resonance imaging (MRI) contrast agent was
conﬁrmed as they exhibited high r1 and r2 relaxivities of 7.95 mM
−1 s−1 and 185.58 mM−1 s−1 respectively at
1.4 T. Biocompatibility and viability of IONPs in primary human mesenchymal stem cells (hMSCs) was
studied and conﬁrmed.
Introduction
Magnetic iron oxide nanoparticles have been the subject of
great interest in recent years due to their various potential bio-
logical applications such as magnetic hyperthermia,1 MRI2–4
drug delivery or cell tracking.5–8 Currently, iron oxide nano-
parZticles such as magnetite (Fe3O4) or its oxidised form,
maghemite (Fe2O3), are the most frequently investigated. This
is due to their biocompatibility, non-toxicity and non-immuno-
genicity in biological systems. Furthermore, they were
approved for clinical applications by the Federal Drug Admin-
istration (FDA) in the 1980s and have since then been commer-
cially available.9 These were developed as contrast agents for
magnetic resonance anatomic imaging of malignant diseases
in organs associated with the reticuloendothelial system (e.g.,
liver, spleen)10–12 and lymph nodes.13 Numerous commercially
available particles such as Feridex© or Resovist© have been
used to label and track hMSCs.14–18 Indeed, in cellular thera-
pies, they represent a valuable tool to monitor the displace-
ment and functionality of transplanted hMSCs in a safe and
eﬀective manner.
Superparamagnetic IONPs may also be used as a multi-
modal platform for other medical applications. The nano-
particle surface provides the stability for these nanoparticles
as well as their functionality by which biological moieties
(antibodies, peptides, drug encapsulation) may potentially be
grafted.19–24 For instance, many studies have recently explored
their therapeutic potential to kill cancer cells by hyperthermia
(heat induced after the application of an alternating magnetic
field) and simultaneous triggered drug delivery.25–27 Further-
more, when a biological moiety (e.g., antibody, peptide) is con-
jugated to the surface of the nanoparticles, the latter may be
actively targeted towards cancer cells to minimise any second-
ary eﬀects from medical treatment on neighbouring healthy
cells.23,28,29 Their small size also allows sub cellular targeting
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which can overcome certain physical barriers that larger
molecules such as pharmaceutical drugs may not.30 Another
application for cellular therapy includes their ability to magne-
tically guide cells especially on tissue-engineered scaﬀolds or
in vivo.31–34
Despite all these advantages, the in vitro and in vivo use of
IONPs faces some challenges. Amongst which is the lack of
reproducibility of synthesis that yield water-dispersible nano-
particles. Indeed, while the co-precipitation of Fe(II) and Fe(III)
ions in the presence of a base is a widespread method in litera-
ture due to the high yields obtained,35,36 the reproducibility of
this route remains questionable.37 The other main synthetic
pathways involve organic solvents which allow a better control
of the size and shape of nanoparticles obtained. However, the
latter involve post synthesis steps to render the nanoparticles
hydrophilic and biocompatible which are diﬃcult to monitor
and control precisely in a quantitative manner.
Recently, water-dispersible IONPs have been developed
through a simple polyol method which involves the thermal
decomposition of iron precursors in a polyol solvent. The
polyol acts as the solvent, a surfactant, as well as the reducing
agent. The polyols are known to reduce the metal salts
to metal nuclei which then nucleate to form metal particles.38
In 2007, Wan et al. synthesised IONPs by this approach under
inert atmosphere.39 The particles obtained were ca. 8 ± 1.1 nm
and with a saturation magnetisation of 80 emu g−1. More
recently, the morphological evolution of IONPs though the
reduction of iron chloride hexahydrate FeCl3·6H2O in ethylene
glycol or 1,2-propylene glycol was investigated and demon-
strated the importance in the choice of solvent regarding the
properties of the nanoparticles.40 This was confirmed with
several recent studies with the use of diethylene glycol, tetra-
ethylene glycol, poly(vinyl alcohol), or 2-pyrrolidone.41–44
Although the exact steps during this reaction have not yet been
clearly identified, a thorough mechanistic study on the
diﬀerent variables during this pathway was investigated by
Miguel-Sancho et al.42,45 The nanoparticles were then further
modified by exchange of the non-covalently bound polyol
molecules with meso-2,3-dimercaptosuccinic acid (DMSA) and
functionalised with an antibody that was successfully recog-
nised by a model anti-rabbit IgG HRP in an indirect ELISA
assay. The biocompatibility and low cytotoxic eﬀects of these
types of particles on HepG2, U87MG, and HeLa cells was also
recently demonstrated.46 However, the obtained IONPs had
several disadvantages such as having a rather low MRI relaxivity
value (r2 = 119 mM
−1 s−1),41 low stability of tri(ethylene glycol)
coated IONPs and aggregation of dimercaptosuccinic acid-
coated IONPs.45 Therefore, obtaining water dispersible IONPs
which have colloidal stability in high concentration of electro-
lytes and a wide range of pH, appropriate surface coatings, high
magnetic moment, and biological compatibility remains a sig-
nificant challenge.
In this work we have adapted the polyol synthesis at high
pressure and high temperature conditions of an autoclave
which allows us to obtain IONPs with enhanced magnetic pro-
perties and better control of their morphology. We attempted
to contribute to a better comprehension of the polyol synthesis
and to improve the properties of the IONPs by carrying out a
systematic study of the process. For this, the conditions were
finely tuned (reaction time, type of solvent and concentration
of iron precursor) and their eﬀects on the final size, mor-
phology and magnetic properties of the obtained NPs were
explored. We also tuned the surface of the IONPs with various
ligands. The suitability of these SPIONs as an MRI contrast
agent and for other biomedical applications was then investi-
gated in vitro with primary hMSCs. The immediate application
of this study is to magnetically label MSCs seeded on a trachea
scaﬀold to detect and track them non-invasively by MRI.
Experimental
Chemicals
Iron(III) acetylacetonate (Fe(acac)3, 99.9%), triethylene glycol
(TREG) (99%), diethylene glycol, DEG, (99%) and acetone were
purchased from VWR, UK; tetraethylene glycol, TEG, (99%),
L-tartaric acid (≥99.5%) and 3,4-dihydroxyhydrocinnamic acid
(98%) were purchased from Sigma-Aldrich. All chemicals were
used as received without further purification.
Nanoparticle synthesis
The magnetic iron oxide nanoparticles were synthesized by a
modified polyol synthesis procedure described by both Cai
and Wan, as well as Maity et al.47,48
In a typical reaction, we used the following reaction con-
ditions: 0.7 g Fe(acac)3 were dissolved in 20 ml of various
polyol solvents, then heated up to 250 °C and maintained at
that temperature during 8 h.
In a typical synthesis, a desired amount of Fe(acac)3 was
mixed with 20 ml of TREG and sonicated during 30 min in
order to homogenise the red dispersion. The resulting mixture
was then transferred into a 45 ml capacity Teflon liner and the
latter was assembled with the autoclave jacket and placed into
an oven (Memmert, model UFP400). The autoclave vessels
have a flat PTFE gasket that is sealed with a screw cap. The
screw caps and bodies of the vessel are made of alloy steel
which allows experimental conditions of up to 300 °C and
maximum working pressure of 1700 psi (115 bar). A pre-set
program was run where the oven heated up to a desired temp-
erature, which was maintained for a required period of time
before ramping down to room temperature (RT) for 2 h. The
resulting black dispersion was washed with acetone three
times and by centrifugation in a Heraeus Biofuge Stratos cen-
trifuge at 8500 rpm for 10 min. The precipitated material was
dispersed in water. This procedure yielded IONPs coated with
polyols. In previous literature, most polyol syntheses of IONPs
are carried out in two heating stages: the first from room temp-
erature to approximately 180 °C, then from 180 °C to the reflux
temperature. This is to ensure the thermal decomposition of
Fe(acac)3 which occurs at 180–190 °C,
49 however we found this
leads to a bimodal distribution of the nanoparticle size
obtained so proceeded without it.
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To explore the eﬀect of the diﬀerent parameters in this syn-
thesis, a combination of experiments was designed in which
the value of one of the parameters in Table 1 was changed at a
time. It should be noted that all reaction conditions were
carried out in triplicate for statistical analysis and it was
shown the synthesis was reproducible.
Modification of the nanoparticle coating
While it is common for IONPs synthesised in organic solvents
to have better control of the shape and size, this process needs
to be followed by a ligand-exchange with a hydrophilic ligand
to render them water dispersible and suitable for biomedical
applications. In our work, the post-synthesis ligand exchange
reaction ensures the stabilisation of the NPs obtained and
eases their functionalization. The concentration of IONPs was
estimated using a Quantum Design superconducting quantum
interference device – vibrating sample magnetometer
(SQUID-VSM) MPMS-3. A solution containing 100 mg MNPs
was mixed with 50 mg of various ligands dissolved in 1 ml of
deionized water: 3,4-dihydroxyhydrocinnamic acid (DHCA) and
tartaric acid (TA). The reaction took place under continuous
stirring for 72 h to ensure the complete displacement of the
polyol by the ligand of choice. Once completed, the excess
ligand was removed by dialysis for 5 days in 5 L of distilled
water (changed daily) by using a 10 kDa molecular weight cut
oﬀ cellulose membrane (SnakeSkin Dialysis Tubing, Fisher
Scientific, UK). The resulting functionalized IONPs were dis-
persed in deionized water.
Characterisation of the nanoparticles obtained
Transmission electron microscopic (TEM) images were
recorded on a JEOL-1200 EX microscope at an accelerating
voltage of 120 kV. The NP dispersions were diluted in de-
ionized water, and dropped onto a carbon-coated copper grid,
and dried at room temperature. The hysteresis loop (at 300 K
and 5 K) was recorded on a SQUID-VSM with applied magnetic
fields between −7 T and 7 T. The saturation magnetisation for
each sample was normalised by taking into account the
organic ligand content measured by thermogravimetric ana-
lysis. The dynamic light scattering and ζ-potential measure-
ments were performed on a Malvern Nanosizer ZS instrument
(Laser He–Ne 633 nm, Malvern Instruments Ltd, Worcester-
shire, UK). For hydrodynamic diameter measurements, 20 µl
of an aqueous solution of IONPs were pipetted into a dispos-
able micro-cuvette (ZEN0040). For ζ-potential measurements,
the NPs were diluted and adjusted to the desired pH (from 3
to 10). ζ-Potential measurements were recorded at 25 °C within
a disposable capillary cell (DTS1070). The ζ-potential was auto-
matically calculated from electrophoretic mobility based on
the Smoluchowski equation, ν = (εE/η)ζ, where ν is the
measured electrophoretic velocity, η is the viscosity, ε is the
electrical permittivity of the electrolytic solution and E is the
electric field. The phase composition of the NPs was character-
ized with a PANalytical XRD using Co Kα (λ = 1.789 Å) radi-
ation. Fourier transform infrared (FTIR) spectroscopy spectra
were recorded on a PerkinElmer spectrometer to confirm the
grafting of ligands on the surface of nanoparticles. The
element analysis of Fe in the samples was measured by induc-
tively coupled plasma atomic emission spectroscopy (ICP-AES).
Thermogravimetric analysis (TGA) was performed for freeze-
dried NP samples with a TGA Seiko Exstar6000 TG/DTA6200
instrument in an inert atmosphere using a heating rate of
10 °C min−1.
Cytotoxicity study
The cytotoxicity of the functionalized nanoparticles was
assessed by an MTS assay with hMSCs. The culture medium
used was αMEM supplemented with 10% FBS (fetal bovine
serum). Cells were seeded in a 96-well plate at a density of
104 cells per well and incubated at 37 °C in a humidified
atmosphere with 5% CO2 and allowed to adhere overnight.
Cell loading with nanoparticles was carried out at various
concentrations up to 1 mg ml−1 for 24 h. Then 20 µl of
the sterile-filtered MTS solution was added to each well. After
4 h of incubation, the absorbance was read at 492 nm
using BMG FluoStar Galaxy Optima Microplate Reader
(Dynex Technologies). All experiments were performed in
triplicate.
Relaxivity studies
A series of IONP aqueous dispersions with diﬀerent Fe concen-
trations (0.25, 0.5, 0.75 and 1 mM) determined by ICP-OES
were prepared for relaxivity studies. All experiments were per-
formed on a Bruker MQ60 NMR Analyzer working at a Larmor
frequency of 60 MHz (1.41 T) and at 37 °C.
Results and discussion
Eﬀect of synthesis parameters
The TEM analysis of IONPs synthesised with diﬀerent polyols
revealed that IONPs obtained with DEG and TREG were within
the superparamagnetic regime with an average size of 5.8 ±
0.8 nm (σ = 14.1%) and 9.1 ± 0.9 (σ = 9.8%) nm respectively
(Fig. 1). On the other hand, when TEG was used, larger nano-
particles of 13.9 nm ± 3.4 nm (σ = 24.5%) were produced with
an increased polydispersity. There is a correlation between the
length of glycol and size of NPs, as the higher the length of the
glycol, the larger the size of the synthesized NPs. We measured
the magnetic properties of these TEG coated IONPs at 300 K,
and showed that they exhibited a superparamagnetic behav-
iour with a saturation magnetisation σs = 79.1 Am
2 kg−1.
A small coercivity Hc = 4.6 Am
2 kg−1 was observed (Fig. 2) since
Table 1 Parameters studied and main characteristics of the solvents
tested
Parameter tested Values
Reaction time (h) 0.5, 1, 2, 4, 8, 12, 24
Mass of Fe(acac)3 (g) 0.35, 0.7, 1.4, 2.1, 3.5
Solvent used DEG, TREG, TEG
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the particle size distribution increased, it is plausible that the
larger IONPs above the superparamagnetic threshold of iron
oxide (15–20 nm) become blocked at 300 K.50
The presence of the diﬀerent polyols on the surface of the
NPs is confirmed by TGA measurements (Fig. S1 in ESI†). The
weight loss occurs in two stages. The first slight weight loss
from approximately 40 to 200 °C corresponds to the removal of
the physically adsorbed water molecules. The second step
from 200 to 570 °C, which represents the most significant loss,
can be attributed to the removal of triethylene glycol in the
sample (or other polyols such as diethylene glycol or tetraethyl-
ene glycol) as the boiling point is in that range.51,52
Diﬀerent sizes of NPs were obtained (Fig. 1) in similar reac-
tion conditions with diﬀerent polyol ligands (Fig. 3) in high
pressure and high temperature conditions. The exact nuclea-
tion/growth process for this reaction remains poorly under-
stood to this day. As observed by Douglas et al., the
mechanism here is not consistent with a classic LaMer
mechanism.53
It is plausible that the higher the length of the carbon
chain of the polyol, the more eﬀective they are as capping
ligands to arrest the growth, hence bigger NPs are obtained as
it was shown to be the case with diﬀerent lengths of poly(ethyl-
ene glycol).54,55
This study confirms that the choice of the solvent is critical
to obtaining high quality nanoparticles with a desired size and
with a narrow size distribution.53,56,57
From these results, it was determined that IONPs produced
in DEG and TREG were suitable for further investigations as
they had a narrow size distribution, are superparamagnetic,
and had a high magnetisation which are desired for bio-
medical applications.58
The reaction time also had an influence on the size of the
nanoparticles obtained and therefore their magnetic pro-
perties. To study this, in a typical synthesis 1.4 g of Fe(acac)3
was dispersed in 20 ml of TREG. The reaction mixture was
then transferred to a 45 ml capacity Teflon lined autoclave
vessel before being heated up to 250 °C and maintained at
that temperature for 1 h, 2 h, 4 h, 8 h, 12 h and 24 h. The
increase in the reaction time from 1 h to 24 h led to an
increase in the size of the NPs obtained from 7.2 nm ± 0.8 nm
(σ = 11%) to 15 nm ± 1.9 nm (σ = 12.5%) (Fig. 4). This corre-
lates to an increase of the saturation magnetization obtained
from 61.2 Am2 kg−1 to 88 Am2 kg−1. Longer reaction times led
to particle growth with narrow size distribution leading us to
believe the reaction mechanism is through coalescence.59 This
allows us to finely control the size of the nanoparticles which
is crucial for their biomedical applications.
Fig. 1 TEM images and particle size distributions of iron oxide nano-
particles synthesized using diﬀerent polyols (A) TEG, (B) TREG and (C)
DEG. Size distributions were ﬁtted with a normal function (solid line),
d = mean diameter, δd = standard deviation and n = number of particles
counted.
Fig. 2 Magnetisation curves of IONPs obtained with diﬀerent polyols
(DEG, TREG and TEG).
Fig. 3 Chemical structure and molecular weight of polyols used in the
synthesis.
Paper Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
1/
01
/2
01
6 
15
:3
1:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
This method, in comparison to previous conventional
polyol methods, has proved to yield water-dispersible IONPs of
which the size and monodispersity can be carefully controlled
with the reaction conditions. In addition, while Wan et al. syn-
thesised IONPs with the classic polyol method using the
Schlenk line,39 our NPs obtained in this work at high pressure
and high temperature conditions lead to higher saturation
magnetisation. When replicating the same chemical reaction
using a conventional set-up consisting of a round bottom
flask, condenser and magnetic stirring we found the IONPs
obtained diﬀerent by their polydispersity and magnetic pro-
perties (Fig. S3†). We measured the magnetic properties of
these TREG coated IONPs at 300 K, and showed that they
exhibited a superparamagnetic behaviour with a saturation
magnetisation σs = 81.8 Am
2 kg−1. While the magnetic pro-
perties are similar with high pressure and high temperature
conditions, the size distribution is much larger with a poly-
dispersity of σ = 18%. We suppose that the high pressure con-
ditions allows a better control of the morphology of the IONPs
obtained hence leading to the lower dispersity. The next step
was to prove how robust this method was in producing re-
producible nanoparticles from one batch to another.
Reproducibility studies
While it was found that the IONPs obtained were consistent
under the same experimental conditions, we decided to invest-
igate the reproducibility of the synthetic conditions in order to
evaluate the suitability of this method for mass-production of
IONPs. Each reaction, using TREG as the polyol capping agent,
was repeated three times and the properties of the NPs
obtained were assessed. We chose a standard condition for the
reaction in which 1.4 g of Fe(acac)3 and 20 mL of TREG were
heated up to 250 °C and maintained at that temperature
during 8 h before cooling down to RT over 2 h. For simplicity,
these reactions are designed by IONP-A, IONP-B and IONP-C.
The results are illustrated in Table 2.
The core size determined by TEM images of three reactions
realised in the same experimental conditions showed a well-
controlled synthesis route with narrow size distribution. Simi-
larly, the crystallite size determined by XRD only presented a
standard deviation of 0.3 nm (Fig. 5).
XRD does not allow distinction between maghemite
(γ-Fe2O3) and magnetite (Fe3O4) phase. Room temperature 57Fe
Mossbauer spectra were recorded on selected samples. These
spectra (not shown) exhibited absorption out to ±8 mm s−1,
indicative of magnetic hyperfine splitting, but were dominated
by a very broad central absorption peak, as is typical of dis-
ordered and/or fine particle materials.60 The mean isomer
Fig. 4 TEM images of iron oxide nanoparticles synthesized using
diﬀerent reaction times in tri(ethylene glycol): (A) 1 h, (B) 2 h, (C) 4 h, (D)
8 h, (E) 12 h, and (F) 24 h.
Table 2 The diameter measured by TEM (DTEM), the crystallite size
obtained by X-ray diﬀraction (DXRD) and saturation magnetisation (Ms)
obtained for 3 reactions repeated in the same conditions
Sample DTEM ± σ TEM (nm) DXRD (nm) Ms (Am
2 kg−1)
IONP-A 9.9 ± 1.1 9.4 70.5
IONP-B 10.9 ± 1.1 8.9 77.8
IONP-C 10.5 ± 1.1 9.3 81.1
Overall average 10.2 ± 1.2 9.2 ± 0.3 76.5 ± 5.4
Fig. 5 XRD pattern of IONPs synthesized in diﬀerent polyol solvents
(DEG, TREG and TEG). Peaks have been indexed according to the refer-
ence pattern for magnetite (pdf ref. 01-088-0315). Diﬀraction patterns
have been normalised and oﬀset along the y-axis for better comparison.
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shift of the spectra, relative to alpha-iron, was determined to
be in the range delta = 0.38 to 0.42 mm s−1. These values lie
between those of pure maghemite (delta = 0.32 mm s−1) and
pure magnetite (delta = 0.53 mm s−1), implying that the
samples were either non-stoichiometric magnetites, or magne-
tite/maghemite composites, or some combination of the two.61
These NPs were well dispersed in water; however we found
that the hydrodynamic diameters obtained were quite large
(above 200 nm) in comparison to the core size determined by
TEM or XRD. Furthermore, sedimentation appeared in the
centrifuge tubes after several days. This led us to believe that
the polyol coating was unstable. Because, even in water or
when salt is added the NPs precipitated out of solution in less
than 30 min. While the exact binding mechanism of polyols to
the surface of iron oxide nanoparticles has not been
established, recent literature suggests that the polyol, such as
DEG, chelates iron. However, the exact structure of this chelate
remains undetermined. Recently, TREG coated IONPs
synthesized by the polyol method in an autoclave or in stan-
dard conditions were found to be unstable and aggregate, as
it is believed that the polyol coating is labile and is
progressively lost, thus leading to the aggregation of the
nanoparticles.45,62
Nanoparticle functionalization
The stabilisation of the NPs obtained is critical for any bio-
medical applications, as IONPs aggregates at physiological pH.
This issue has been addressed by many groups, and a number
of ligands have shown to interact with IONPs and to stabilise
them, these include phosphonates,63,64 poly(ethylene
glycol),65–67 siloxanes,68,69 or various starch molecules such as
dextran.70,71 Another group of interest are carboxylic ligands
such as citric acid,1,6 dimercaptosuccinic acid (DMSA)72–74 or
folic acid75 which have been used recently on the surface of
IONPs as they can provide biocompatibility, stability and tar-
geting properties.76–78 In addition to the previously stated ones,
we tested a variety of ligands to optimise the stabilisation
process by charge or steric hindrance. Two ligands were shown
to be successful: 3,4-dihydroxyhydrocinnamic acid
(IONP-DHCA) and tartaric acid (IONP-TA). As mentioned pre-
viously, 100 mg of IONP-TREG was mixed with 50 mg of ligand
and left under continuous stirring during 72 h. Once com-
pleted, the excess ligand was removed by dialysis and the result-
ing functionalized IONPs were dispersed in deionized water.
After the ligand exchange step, the hydrodynamic size of
the IONPs decreased: 154 nm and 193 nm in water for the
IONP-DHCA and IONP-TA respectively (Fig. S2 and S3†), in
comparison to the 270 nm for TREG coated IONPs. This con-
firms that the ligands help stabilise the particles and prevent
aggregation.79 In PBS, the hydrodynamic diameter of
IONP-DHCA decreased to 140 nm, and no aggregation was
observed (Fig. S2†). The hydrodynamic diameter in serum
containing media, Roswell Park Memorial Institute (RPMI)
medium containing 10% Fetal Bovine Serum) was also
measured (Fig. S8†). We were able to decrease the hydro-
dynamic diameter down to approximately 85 nm in water and
104 nm in PBS when increasing the dialysis time up to 7 days
(Fig. S9†). Furthermore, IONP-TA did show slight aggregation
in water which became more significant in PBS with a hydro-
dynamic diameter that increased to 243 nm (Fig. S3†). Due to
the smaller hydrodynamic diameter obtained with DHCA, we
decided to study the long term stability of IONP-DHCA.
72 days later, the IONP-DHCA in water remained stable with a
measured diameter of 140 nm. Moreover, the zeta potential is
strongly negative (Fig. 6): −46.8 mV for IONP-DHCA and
−35.5 mV for IONP-TA, which confirms the stability of these
IONPs in moderate electrolyte conditions (100 mM NaCl was
tested). In the case of IONP-DHCA, the catechol functional
groups are attached to the nanoparticles, and therefore the
carboxylic groups remain unbound, which provide the negative
surface charge and are ideal for any further surface
functionalization. In the case of IONP-TA, one of the carboxylic
groups is an anchor to the nanoparticle and the other one pro-
vides the negative surface charge and functionality as it
remains unbound.
The ligand exchange of IONP-TREG with DHCA was con-
firmed by FT-IR measurements. The corresponding FT-IR
spectra are displayed in Fig. 7. For polyol coated NPs, bands at
Fig. 6 Evolution of zeta potential in NaCl 100 mM of the functionalized
iron oxide nanoparticles after coating with DHCA and TA, as a function
of the pH.
Fig. 7 ATR-FTIR spectrum of IONPs coated with 2,3-dihydroxyhydro-
cinnamic acid (DHCA) and tartaric acid (TA). The 1720–4000 cm−1 range
has been excluded as no signiﬁcant information was found.
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1116–1050 cm−1 are characteristic of C–O stretching and
confirm the attachment of TREG on the surface (Fig. S11†).
The broad band (3600–2500 cm−1) centred around
3400 cm−1 is due to hydrogen bonded O–H stretching
vibration from surface hydroxyl groups on nanoparticles and
adsorbed TREG and water.80 The characteristic Fe–O stretching
vibration band is also present at 540 and 545 cm−1.81,82
In the case of DHCA functionalized NPs, the broad band at
approximately 1490 cm−1 and peaks at 1247 cm−1 are present
when catechol binds covalently to various metal oxides as cate-
chol anions.83 They can be attributed to the benzene ring
vibration and a C–O stretch, respectively. The band at
1403 cm−1 was assigned to symmetric vibrations of carboxyl
groups COO− and COOH.
Tartaric acid functionalized NPs also exhibited specific
peaks. At 1613 cm−1 a sharp peak corresponds to the asym-
metric stretching of carboxylic groups, and is shifted towards
lower wavenumber as it is bound to the surface of the NPs.84,85
The band observed at 1089 cm−1 is due to the C–O stretch in
hydroxyl groups, and the band observed at 1370 cm−1 is
characteristic of the bending of alkanes –C–H. Both bands can
be attributed to the bound tartaric acid on the surface of NPs.
The broad band (3600–2500 cm−1) centred around 3400 cm−1
is due to hydrogen bonded O–H stretching vibration from
surface hydroxyl groups on nanoparticles and adsorbed TREG
and water, therefore it cannot be attributed specifically to the
hydroxyl groups of tartaric acid.80
In vitro characterization
We next investigated the ability of the functionalized nano-
particles as MRI contrast agent by performing the relaxivity
measurements at 1.4 T. We prepared samples of four diﬀerent
concentrations of Fe up to 1 mM (determined by ICP-AES). We
measured the r1 and r2 values according to the linear relation-
ship of longitudinal and transverse relaxation rates versus the
magnetic metal concentrations of Fe2O3 (Fig. 8). The IONP-DHCA
nanoparticles exhibited the highest relaxation enhancement,
with an r2 value of 185.58 mM
−1 s−1 and r1 of 7.95 mM
−1 s−1 at
1.4 T. For tartaric acid functionalized nanoparticles, the r2
decreases to 149.68 mM−1 s−1 and r1 increases to 8.63 mM
−1
s−1. The relatively high r2/r1 ratio (Table 3) suggests these
nanoparticles are T2 weighted contrast agents.
At the same frequency, in comparison to FDA-approved
nanoparticles for MRI Resovist® and Endorem®, the NPs
obtained had an improved r2/r1 ratio by a factor of more than
3.86 Furthermore, the promising features of these IONPs as
MRI contrast agents was confirmed with relaxivity measure-
ments of IONPs obtained in the same manner as the previous
IONP-DHCA sample but being maintained at 250 °C during
12 h and 24 h (Table 3), thus having higher saturation magne-
tisation of 84.1 and 85.4 emu g−1 respectively (Fig. S12†).
Biocompatibility is the bottleneck of many of today’s
current applications of nanomaterials in biomedical appli-
cations. To verify the suitability of the functionalized NPs, cell
proliferation was measured by an MTS assay. Fig. 9 shows the
Fig. 8 Top plot of relaxation rate 1/T1 over Fe2O3 concentration of the
IO-DHCA nanoparticles. The slope indicates the speciﬁc relaxivity (r1);
bottom plot of 1/T2 over Fe2O3 concentration of the IO-DHCA nano-
particles. The slope indicates the speciﬁc relaxivity (r2). ○ IONP-TA and
Δ IONP-DHCA.
Table 3 Relaxivities for IONPs functionalized with 3,4-dihydroxyhydro-
cinnamic acid (DHCA) or tartaric acid (TA) at 1.4 T
r2 (mM
−1 s−1) r1 (mM
−1 s−1) r2/r1
IONP-DHCA 8 h 185.58 7.95 23.3
IONP-TA 8 h 149.68 8.63 17.3
IONP-DHCA 12 h 160.6 5.16 31.1
IONP-DHCA 24 h 259.1 9.9 26.2
Endorem® 41 4.7 8.72
Resovist® 61 8.7 7
Fig. 9 Cell proliferation of hMSCs after being incubated with
IONP-DHCA and IONP-TA during 24 h at various concentrations. Data
indicated as the mean ± standard deviation of 3 independent experi-
ments. *p < 0.05 and **p < 0.01.
Nanoscale Paper
This journal is © The Royal Society of Chemistry 2015 Nanoscale
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
O
ct
ob
er
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
1/
01
/2
01
6 
15
:3
1:
28
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
eﬀect of IONPs on cell proliferation after incubation at various
concentrations for 24 h.
There is no significant diﬀerence in cell viability for both types
of nanoparticles up to 500 μg ml−1. However, there is significant
decrease in viability at concentrations of 1 mg ml−1, at 60% for
IONP-DHCA and 45% for IONP-TA relative to the control.
These results demonstrate that the functionalized iron
oxide nanoparticles have excellent biocompatibility and little
toxicity is observed for the nanoparticles that could be used as
MRI T2 contrast agents in hMSCs.
Conclusions
In summary, water-dispersible IONPs have been successfully
obtained via a simple and reproducible polyol synthesis modi-
fied by using high pressure and high temperature conditions.
Their size and magnetic properties could be finely tuned by
modifying the solvent, reaction time and concentration of iron
precursor Fe(acac)3. The as-synthesised nanoparticles had a
high saturation magnetization (ca. 80 emu g−1) but were not
stable as indicated by the hydrodynamic diameter measure-
ments and their precipitation in solution. The modification of
the TREG coating by a ligand exchange process yielded stable
nanoparticles with carboxylic ligands: 3,4-dihydroxyhydro-
cinnamic acid (IONP-DHCA) and tartaric acid (IONP-TA). The
best results were obtained with IONP-DHCA which demon-
strated long term stability, even when subjected to various salt
concentrations (up to 1 M NaCl). The potential of these novel
particles as MRI contrast agents is demonstrated with better
relaxivity values when compared to commercial contrast agents:
r2 = 185.58 mM
−1 s−1 and r1 = 7.95 mM
−1 s−1 for IONP-DHCA
while r2 = 149.68 mM
−1 s−1 and r1 = 8.63 mM
−1 s−1 for
IONP-TA. We believe that such highly magnetic and stable iron
oxide nanoparticles hold great promise in serving as novel and
eﬀective MRI contrast agents for applications such as stem cell
tracking or cancer cell targeted imaging for example.
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